Randomized, multicenter, phase 3 study of 1st-line irinotecan+5FU/folinic acid vs cisplatin+5FU in patients with advanced gastric cancer - quality of life analysis için istatistikler

Toplam ziyaret

views
Randomized, multicenter, phase 3 study of 1st-line irinotecan+5FU/folinic acid vs cisplatin+5FU in patients with advanced gastric cancer - quality of life analysis 0

Aylık toplam ziyaret

views
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0
Mayıs 2025 0
Haziran 2025 0
Temmuz 2025 0